TherapeuticsMD Inc
Change company Symbol lookup
Select an option...
TXMD TherapeuticsMD Inc
NVEC NVE Corp
GHRS GH Research PLC
NWFL Norwood Financial Corp
APN Apeiron Capital Investment Corp
TSLA Tesla Inc
TOL Toll Brothers Inc
LHAA Lerer Hippeau Acquisition Corp
PSUD Petrosun Inc
ADIL Adial Pharmaceuticals Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products from pregnancy prevention through menopause. Its contraceptive products include ANNOVERA. ANNOVERA (segesterone acetate (SA) and ethinyl estradiol (EE) vaginal system) is a one-year ring-shaped contraceptive vaginal system (CVS) and patient-controlled, procedure-free, reversible prescription contraceptive. Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy due to menopause. (estradiol and progesterone) capsules is a bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. Its prenatal vitamin products include vitaTrue, vitaPearl, and BocaGreenMD Prena1 True.

Closing Price
$6.22
Day's Change
-0.13 (-2.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.41
Day's Low
6.11
Volume
(Average)
Volume:
88,619

10-day average volume:
96,558
88,619
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.